1963 related articles for article (PubMed ID: 32612154)
61. Ovarian Cancer Immunotherapy: Turning up the Heat.
Ghisoni E; Imbimbo M; Zimmermann S; Valabrega G
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31208030
[TBL] [Abstract][Full Text] [Related]
62. Towards a Systems Immunology Approach to Unravel Responses to Cancer Immunotherapy.
Bracci L; Fragale A; Gabriele L; Moschella F
Front Immunol; 2020; 11():582744. PubMed ID: 33193392
[TBL] [Abstract][Full Text] [Related]
63. Turning Cold into Hot: Firing up the Tumor Microenvironment.
Duan Q; Zhang H; Zheng J; Zhang L
Trends Cancer; 2020 Jul; 6(7):605-618. PubMed ID: 32610070
[TBL] [Abstract][Full Text] [Related]
64. From Oncogenic Signaling Pathways to Single-Cell Sequencing of Immune Cells: Changing the Landscape of Cancer Immunotherapy.
Derakhshani A; Rostami Z; Safarpour H; Shadbad MA; Nourbakhsh NS; Argentiero A; Taefehshokr S; Tabrizi NJ; Kooshkaki O; Astamal RV; Singh PK; Taefehshokr N; Alizadeh N; Silvestris N; Baradaran B
Molecules; 2021 Apr; 26(8):. PubMed ID: 33920054
[TBL] [Abstract][Full Text] [Related]
65. Phenotyping of tumor infiltrating immune cells using mass-cytometry (CyTOF).
Maby P; Corneau A; Galon J
Methods Enzymol; 2020; 632():339-368. PubMed ID: 32000904
[TBL] [Abstract][Full Text] [Related]
66. Therapeutic Potential of Lymphoid Infiltrates in Breast Cancer.
Chen XY; Tan PH
Curr Med Chem; 2021; 28(25):5152-5178. PubMed ID: 33938409
[TBL] [Abstract][Full Text] [Related]
67. Technology meets TILs: Deciphering TÂ cell function in the -omics era.
Hudson WH; Wieland A
Cancer Cell; 2023 Jan; 41(1):41-57. PubMed ID: 36206755
[TBL] [Abstract][Full Text] [Related]
68. Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune-Checkpoint Blockade.
Chon HJ; Lee WS; Yang H; Kong SJ; Lee NK; Moon ES; Choi J; Han EC; Kim JH; Ahn JB; Kim JH; Kim C
Clin Cancer Res; 2019 Mar; 25(5):1612-1623. PubMed ID: 30538109
[TBL] [Abstract][Full Text] [Related]
69. Immune checkpoints in the tumor microenvironment.
Toor SM; Sasidharan Nair V; Decock J; Elkord E
Semin Cancer Biol; 2020 Oct; 65():1-12. PubMed ID: 31265893
[TBL] [Abstract][Full Text] [Related]
70. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.
Thomas R; Al-Khadairi G; Roelands J; Hendrickx W; Dermime S; Bedognetti D; Decock J
Front Immunol; 2018; 9():947. PubMed ID: 29770138
[TBL] [Abstract][Full Text] [Related]
71. Mechanisms and therapeutic potentials of cancer immunotherapy in combination with radiotherapy and/or chemotherapy.
Yu WD; Sun G; Li J; Xu J; Wang X
Cancer Lett; 2019 Jun; 452():66-70. PubMed ID: 30902563
[TBL] [Abstract][Full Text] [Related]
72. Comprehensive analyses of tumor immunity: implications for cancer immunotherapy.
Li B; Severson E; Pignon JC; Zhao H; Li T; Novak J; Jiang P; Shen H; Aster JC; Rodig S; Signoretti S; Liu JS; Liu XS
Genome Biol; 2016 Aug; 17(1):174. PubMed ID: 27549193
[TBL] [Abstract][Full Text] [Related]
73. Prospects for personalized combination immunotherapy for solid tumors based on adoptive cell therapies and immune checkpoint blockade therapies.
Kato D; Yaguchi T; Iwata T; Morii K; Nakagawa T; Nishimura R; Kawakami Y
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):68-77. PubMed ID: 28539557
[TBL] [Abstract][Full Text] [Related]
74. Applications of Single-Cell Omics to Dissect Tumor Microenvironment.
Guo T; Li W; Cai X
Front Genet; 2020; 11():548719. PubMed ID: 33329692
[TBL] [Abstract][Full Text] [Related]
75. Cell transfer-based immunotherapies in cancer: A review.
Gorabi AM; Hajighasemi S; Sathyapalan T; Sahebkar A
IUBMB Life; 2020 Apr; 72(4):790-800. PubMed ID: 31633881
[TBL] [Abstract][Full Text] [Related]
76. CU06-1004-Induced Vascular Normalization Improves Immunotherapy by Modulating Tumor Microenvironment
Park S; Oh JH; Park DJ; Zhang H; Noh M; Kim Y; Kim YS; Kim H; Kim YM; Ha SJ; Kwon YG
Front Immunol; 2020; 11():620166. PubMed ID: 33584714
[TBL] [Abstract][Full Text] [Related]
77. Where have all the T cells gone? Mechanisms of immune evasion by tumors.
Finke J; Ferrone S; Frey A; Mufson A; Ochoa A
Immunol Today; 1999 Apr; 20(4):158-60. PubMed ID: 10203710
[No Abstract] [Full Text] [Related]
78. Recruiting T cells in cancer immunotherapy.
Yost KE; Chang HY; Satpathy AT
Science; 2021 Apr; 372(6538):130-131. PubMed ID: 33833111
[No Abstract] [Full Text] [Related]
79. Cellular immunotherapy of cancer: an overview and future directions.
Tao Z; Li S; Ichim TE; Yang J; Riordan N; Yenugonda V; Babic I; Kesari S
Immunotherapy; 2017 Jun; 9(7):589-606. PubMed ID: 28595516
[TBL] [Abstract][Full Text] [Related]
80. Innate myeloid cells in the tumor microenvironment.
Duhan V; Smyth MJ
Curr Opin Immunol; 2021 Apr; 69():18-28. PubMed ID: 33588308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
